{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:00:46Z","timestamp":1780290046042,"version":"3.54.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Apolipoprotein E (\n                    <jats:italic>APOE<\/jats:italic>\n                    ) genotype and cardiovascular risk are both associated with dementia, but their separate and joint contributions remain uncertain. We examined the independent and combined associations of\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype and cardiovascular disease (CVD) risk with incident dementia in a Norwegian populationbased cohort. In this prospective cohort study, baseline data were obtained from the second Tr\u00f8ndelag Health Study (HUNT2, 1995\u201397), with follow-up through linkage to specialist health-care records and the Norwegian Cause of Death Registry through Dec 31, 2023. We included 22,108 participants aged 50 years or older who were free of CVD, diabetes, and dementia at baseline.\n                    <jats:italic>APOE<\/jats:italic>\n                    genetic risk and cardiovascular risk based on SCORE2 were each classified into three categories. Adjusted hazard ratios (HRs) for incident dementia were estimated using Cox models. During a median follow-up of 22.0 years, 3,714 incident dementia events occurred. Compared with low\n                    <jats:italic>APOE<\/jats:italic>\n                    genetic risk, adjusted HRs were 1.25(95% CI1.10\u20131.41) for intermediate risk and 3.09(2.73\u20133.49) for high risk. Compared with low-to-moderate CVD risk, adjusted HRs were 1.19(1.07\u20131.32) for high risk and 1.36(1.19\u20131.55) for very high risk. In joint analyses, the highest risk was observed in participants with high\n                    <jats:italic>APOE<\/jats:italic>\n                    genetic risk and very high cardiovascular risk (HR 3.78, 2.85\u20135.01). Higher cardiovascular risk was more clearly associated with dementia in participants without high\n                    <jats:italic>APOE<\/jats:italic>\n                    genetic risk, whereas dementia risk was consistently elevated across cardiovascular risk categories among those with high\n                    <jats:italic>APOE<\/jats:italic>\n                    genetic risk. There was no clear evidence of multiplicative interaction (\n                    <jats:italic>p<\/jats:italic>\n                    =0.059).\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype and cardiovascular risk were independently associated with incident dementia, with highest risk among individuals with both high genetic and cardiovascular risk.\n                  <\/jats:p>","DOI":"10.1007\/s10654-026-01412-3","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:11:41Z","timestamp":1780287101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["APOE genotype, cardiovascular risk, and incident dementia in the Norwegian HUNT study"],"prefix":"10.1007","author":[{"given":"Nora","family":"Gr\u00f8tting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-1552","authenticated-orcid":false,"given":"Brooke N.","family":"Wolford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8038-917X","authenticated-orcid":false,"given":"Kirsti","family":"Kval\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-0369","authenticated-orcid":false,"given":"Torbj\u00f8rn","family":"Omland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6511-8219","authenticated-orcid":false,"given":"Geir","family":"Selb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-4699","authenticated-orcid":false,"given":"Linda","family":"Ernstsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"1412_CR1","unstructured":"Organization WH. Dementia [Fact sheet]. 2025."},{"issue":"10452","key":"1412_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/s0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572\u2013628. https:\/\/doi.org\/10.1016\/s0140-6736(24)01296-0.","journal-title":"Lancet"},{"issue":"16","key":"1412_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"2","key":"1412_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, et al. APOE \u03b54 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013;70(2):223\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2013.600.","journal-title":"JAMA Neurol"},{"issue":"33","key":"1412_CR5","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","volume":"40","author":"KL Rasmussen","year":"2019","unstructured":"Rasmussen KL, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105\u2009949 individuals from a white general population cohort. Eur Heart J. 2019;40(33):2813\u201324. https:\/\/doi.org\/10.1093\/eurheartj\/ehz402.","journal-title":"Eur Heart J"},{"issue":"9","key":"1412_CR6","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(9):2672\u2013713. https:\/\/doi.org\/10.1161\/STR.0b013e3182299496.","journal-title":"Stroke"},{"issue":"25","key":"1412_CR7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 risk prediction algorithms","year":"2021","unstructured":"SCORE2 risk prediction algorithms. : new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309.","journal-title":"Eur Heart J"},{"issue":"25","key":"1412_CR8","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","volume":"42","author":"SCORE2-OP risk","year":"2021","unstructured":"SCORE2-OP risk. prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455\u201367. https:\/\/doi.org\/10.1093\/eurheartj\/ehab312.","journal-title":"Eur Heart J"},{"issue":"2","key":"1412_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41569-021-00607-3","volume":"19","author":"N Townsend","year":"2022","unstructured":"Townsend N, Kazakiewicz D, Wright L, et al. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19(2):133\u201343. https:\/\/doi.org\/10.1038\/s41569-021-00607-3.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1412_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/gerona\/glac251","volume":"78","author":"F Zheng","year":"2023","unstructured":"Zheng F, Xie W, Li C, Gao D, Liang J. Prediction abilities of SCORE2 risk algorithms for incident dementia and all-cause mortality: results from the UK Biobank Cohort Study. J Gerontol A Biol Sci Med Sci. 2023;78(4):704\u201310. https:\/\/doi.org\/10.1093\/gerona\/glac251.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1412_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000535284","volume":"70","author":"S Vishwanath","year":"2024","unstructured":"Vishwanath S, Hopper I, Chowdhury E, et al. Cardiovascular disease risk scores and incident dementia and cognitive decline in older men and women. Gerontology. 2024;70(2):143\u201354. https:\/\/doi.org\/10.1159\/000535284.","journal-title":"Gerontology"},{"issue":"9","key":"1412_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/s1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 2011;10(9):819\u201328. https:\/\/doi.org\/10.1016\/s1474-4422(11)70072-2.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1412_CR13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","volume":"74","author":"RF Gottesman","year":"2017","unstructured":"Gottesman RF, Albert MS, Alonso A, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. JAMA Neurol. 2017;74(10):1246\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1658.","journal-title":"JAMA Neurol"},{"issue":"5","key":"1412_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida I, Hannon E, Littlejohns TJ, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430\u20137. https:\/\/doi.org\/10.1001\/jama.2019.9879.","journal-title":"JAMA"},{"issue":"6","key":"1412_CR15","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1002\/alz.13801","volume":"20","author":"J Neuffer","year":"2024","unstructured":"Neuffer J, Wagner M, Moreno E, et al. Association of lifestyle for brain health risk score (LIBRA) and genetic susceptibility with incident dementia and cognitive decline. Alzheimers Dement. 2024;20(6):4250\u20139. https:\/\/doi.org\/10.1002\/alz.13801.","journal-title":"Alzheimers Dement"},{"key":"1412_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072691","volume":"380","author":"J Jia","year":"2023","unstructured":"Jia J, Zhao T, Liu Z, et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380:e072691. https:\/\/doi.org\/10.1136\/bmj-2022-072691.","journal-title":"BMJ"},{"issue":"9","key":"1412_CR17","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41591-019-0547-7","volume":"25","author":"S Licher","year":"2019","unstructured":"Licher S, Ahmad S, Karamuji\u0107-\u010comi\u0107 H, et al. Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nat Med. 2019;25(9):1364\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0547-7.","journal-title":"Nat Med"},{"issue":"7","key":"1412_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.24031","volume":"6","author":"H Duan","year":"2023","unstructured":"Duan H, Zhou D, Xu N, et al. Association of unhealthy lifestyle and genetic risk factors with mild cognitive impairment in Chinese older adults. JAMA Netw Open. 2023;6(7):e2324031. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.24031.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1412_CR19","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/s2666-7568(24)00066-7","volume":"5","author":"M R\u00e9gy","year":"2024","unstructured":"R\u00e9gy M, Dugravot A, Sabia S, et al. The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies. Lancet Healthy Longev. 2024;5(6):e422\u201330. https:\/\/doi.org\/10.1016\/s2666-7568(24)00066-7.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"1412_CR20","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1093\/ije\/dyac095","volume":"52","author":"BO \u00c5svold","year":"2023","unstructured":"\u00c5svold BO, Langhammer A, Rehn TA, et al. Cohort profile update: The HUNT study, Norway. Int J Epidemiol. 2023;52(1):e80\u201391. https:\/\/doi.org\/10.1093\/ije\/dyac095.","journal-title":"Int J Epidemiol"},{"key":"1412_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyae073","author":"M N\u00e6ss","year":"2024","unstructured":"N\u00e6ss M, Kval\u00f8y K, S\u00f8rgjerd EP, et al. Data resource profile: the HUNT Biobank. Int J Epidemiol. 2024. https:\/\/doi.org\/10.1093\/ije\/dyae073.","journal-title":"Int J Epidemiol"},{"issue":"34","key":"1412_CR22","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"issue":"10","key":"1412_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100193","volume":"2","author":"BM Brumpton","year":"2022","unstructured":"Brumpton BM, Graham S, Surakka I, et al. The HUNT study: a population-based cohort for genetic research. Cell Genom. 2022;2(10):100193. https:\/\/doi.org\/10.1016\/j.xgen.2022.100193.","journal-title":"Cell Genom"},{"issue":"6","key":"1412_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10654-007-9110-9","volume":"22","author":"N Kurtze","year":"2007","unstructured":"Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-reported physical activity in the Nord-Tr\u00f8ndelag health study (HUNT 2). Eur J Epidemiol. 2007;22(6):379\u201387. https:\/\/doi.org\/10.1007\/s10654-007-9110-9.","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"1412_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/s0959-8049(03)00151-5","volume":"39","author":"L Thorsen","year":"2003","unstructured":"Thorsen L, Nystad W, Dahl O, et al. The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer. 2003;39(9):1216\u201321. https:\/\/doi.org\/10.1016\/s0959-8049(03)00151-5.","journal-title":"Eur J Cancer"},{"issue":"12","key":"1412_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013.","journal-title":"Int J Surg"},{"issue":"3","key":"1412_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03.","journal-title":"J Stat Softw"},{"key":"1412_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987."},{"issue":"4","key":"1412_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-Value. Ann Intern Med. 2017;167(4):268\u201374. https:\/\/doi.org\/10.7326\/m16-2607.","journal-title":"Ann Intern Med"},{"key":"1412_CR30","unstructured":"Therneau TM. A Package for Survival Analysis in R. R package version 3.8-32024."},{"issue":"1","key":"1412_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03557-8","volume":"24","author":"S Ye","year":"2024","unstructured":"Ye S, Roccati E, Wang W, et al. Leading determinants of incident dementia among individuals with and without the Apolipoprotein E \u03b54 genotype: a retrospective cohort study. BMC Neurol. 2024;24(1):71. https:\/\/doi.org\/10.1186\/s12883-024-03557-8.","journal-title":"BMC Neurol"},{"issue":"2","key":"1412_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318. https:\/\/doi.org\/10.1038\/nrneurol.2012.263.","journal-title":"Nat Rev Neurol"},{"key":"1412_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2025.100802","author":"M Ellingjord-Dale","year":"2025","unstructured":"Ellingjord-Dale M, Strand BH, Skirbekk V, et al. Potentially modifiable risk factors for dementia in Norway (HUNT4 70+): a retrospective cohort study. Lancet Healthy Longev. 2025. https:\/\/doi.org\/10.1016\/j.lanhl.2025.100802.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"1412_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/jad-240037","volume":"99","author":"L Gj\u00f8ra","year":"2024","unstructured":"Gj\u00f8ra L, Strand BH, Bergh S, et al. Prevalence and determinants of diagnosed dementia: a registry linkage study linking diagnosis of dementia in the population-based HUNT study to registry diagnosis of dementia in primary care and hospitals in Norway. J Alzheimers Dis. 2024;99(1):363\u201375. https:\/\/doi.org\/10.3233\/jad-240037.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1412_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12479","volume":"15","author":"B Johnsen","year":"2023","unstructured":"Johnsen B, Martinaityte I, Wilsgaard T, Schirmer H. Incidence of dementia over a period of 20 years in a Norwegian population. Alzheimers Dement Amst. 2023;15(4):e12479. https:\/\/doi.org\/10.1002\/dad2.12479.","journal-title":"Alzheimers Dement Amst"},{"issue":"1","key":"1412_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2288-12-143","volume":"12","author":"A Langhammer","year":"2012","unstructured":"Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J. The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC Med Res Methodol. 2012;12(1):143. https:\/\/doi.org\/10.1186\/1471-2288-12-143.","journal-title":"BMC Med Res Methodol"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-026-01412-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:11:42Z","timestamp":1780287102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-026-01412-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":36,"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1007\/s10654-026-01412-3","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GS reports honoraria for delivering lectures at symposia sponsored by Eisai and Eli Lilly and participating in advisory board meetings for Roche, Eli Lilly, and Eisai regarding disease-modifying drugs for Alzheimer\u2019s disease. TO reports institutional research support from Roche Diagnostics, Abbott Diagnostics, and Novartis, consulting fees from Roche Diagnostics, Abbott Diagnostics, and SpinChip, and membership of a DMC for a study sponsored by Novo Nordisk. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants in the HUNT Study provided written informed consent. The present study was approved by the Regional Committee for Medical and Health Research Ethics in Norway (REC 672635). Data collection, storage, and analysis comply with the General Data Protection Regulation (GDPR).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}